The Effects of Nicotine Chewing Gum in Parkinson's Disease

NCT02452125 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2017-07-28

No results posted yet for this study

Summary

The objective of this experiment is:

To determine if nicotine chewing gum will improve acute episodes of orthostatic hypotension in PD subjects.

Conditions

  • Low Blood Pressure
  • Parkinsons Disease

Interventions

DIETARY_SUPPLEMENT

Nicotine gum

Nicotine chewing gum

Sponsors & Collaborators

  • New York Institute of Technology

    lead OTHER

Principal Investigators

  • Joanne Donoghue, PhD · New York Institute of Technology

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2017-06-01
Completion
2017-06-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02452125 on ClinicalTrials.gov